Literature DB >> 30922313

Correction to: Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals.

Liz Morrell1,2, Sarah Wordsworth3,4, Anna Schuh5, Mark R Middleton5, Sian Rees6, Richard W Barker7.   

Abstract

.

Entities:  

Year:  2019        PMID： 30922313      PMCID： PMC6437939          DOI： 10.1186/s12913-019-4039-8

Source DB:  PubMed          Journal:  BMC Health Serv Res        ISSN： 1472-6963            Impact factor:   2.655


× No keyword cloud information.
Correction to: BMC Health Serv Res (2018) 18:393 https://doi.org/10.1186/s12913-018-3162-2 In the original publication of this article [1], the Acknowledgements section lacks of important funding information “This project was funded by the NIHR Oxford Biomedical Research Centre BRC”. The authors apologize for any inconvenience that it may have caused.
  1 in total

1.  Will the reformed Cancer Drugs Fund address the most common types of uncertainty? An analysis of NICE cancer drug appraisals.

Authors:  Liz Morrell; Sarah Wordsworth; Anna Schuh; Mark R Middleton; Sian Rees; Richard W Barker
Journal:  BMC Health Serv Res       Date:  2018-05-31       Impact factor: 2.655
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.